|
Bendroflumethiazide Tablets
» Bendroflumethiazide Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C15H14F3N3O4S2.
Packaging and storage
Preserve in tight containers.
Identification
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Dissolution
Medium:
0.01 N hydrochloric acid; 900 mL.
Apparatus 2:
50 rpm.
Time:
45 minutes.
Procedure
Determine the amount of C15H14F3N3O4S2 dissolved by employing UV absorption at the wavelength of maximum absorbance at about 271 nm on filtered portions of the solution under test, suitably diluted with water, if necessary, in comparison with a Standard solution having a known concentration of USP Bendroflumethiazide RS in the same Medium.
Tolerances
Not less than 75% (Q) of the labeled amount of C15H14F3N3O4S2 is dissolved in 45 minutes.
Uniformity of dosage units
Assay
[noteUse low-actinic glassware for the Assay preparation and the Standard preparation.]
Mobile phase
Dissolve 5.62 g of sodium chloride and 1.97 g of anhydrous sodium acetate in 1000 mL of water in a 2-liter volumetric flask. Add 4.0 mL of glacial acetic acid and 800 mL of methanol, dilute with water to volume, mix, filter, and degas.
Standard preparation
Dissolve an accurately weighed quantity of USP Bendroflumethiazide RS in methanol, and dilute quantitatively and stepwise with methanol to obtain a solution having a known concentration of about 50 µg per mL.
Assay preparation
Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 5 mg of bendroflumethiazide, to a 100-mL volumetric flask, add about 70 mL of methanol, and sonicate for 15 minutes, with occasional shaking. Dilute with methanol to volume, mix, and centrifuge a portion of the solution for 15 minutes.
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the response of the major peak. Calculate the quantity, in mg, of C15H14F3N3O4S2 in the portion of Tablets taken by the formula:
0.1C(rU / rS)
in which C is the concentration, in µg per mL, of USP Bendroflumethiazide RS in the Standard preparation, and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 1637
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|